// App-Quantinova.ai

: Results of the Compassionate Program of Inotuzumab Ozogamicin for Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia in Spain

Researchers

Presenter

  • Josep-Maria Ribera

Principal Investigators

  • Olga Garcia

  • Pau Montesinos

  • Rebeca Rodriguez-Veiga

  • María García-Fortes

  • Abelardo Barez Garcia

  • Itziar Oiartzabal

  • Jose A Gonzalez-Campos

  • Jose Angel Mendez Sanchez

  • Maite Zudaire

  • Lucia Villalon

  • Oriana Lopez-Godino

  • Cristina Gil

  • Ana Vicent

  • Raquel Saldaña

  • Marta Valero

  • Anna Torrent

  • Jesus Maria Hernandez-Rivas

Medical Centers

  • Hospital Arnau de Vilanova, Valencia, Spain

  • Department of Hematology, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Center, Salamanca, Spain

  • Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain

  • Hematology Department, Hospital Universitario Morales Meseguer, Murcia, Spain

  • H.Nuestra Señora de Sonsoles.Ávila, Avila, ESP

  • Complejo Hospitalario Ourense, OURENSE, ESP

  • Hospital Universitario Virgen De La Victoria, MáLaga, ESP

  • Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain

  • Hospital de Jerez, Jerez de la Frontera, Spain

  • Fundacion Alcorcon Hospital, MADRID, Spain

  • Hematology Department., Hospital Universitario Araba, Vitoria-Gasteiz, Spain

  • Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain

  • Hematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain

  • Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain

  • ICO-Hospital Joan XXIII, Tarragona, Spain

  • Complejo Hospitalario de Navarra, Pamplona, Spain

  • Hospital Universitario y Politécnico Le Fe, Valencia, Spain

Locations

  • Spain

  • Venezuela

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Liver Disease

  • Hepatitis B

  • Human immunodeficiency virus infection

Biomarkers

  • Aspartate aminotransferase

  • Alanine transaminase

  • Breakpoint Cluster Region

  • Bilirubin

Drug/Treatment

  • Inotuzumab ozogamicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved